JAN (NYSE:JAN) Downgraded by Zacks Research to Hold

Zacks Research cut shares of JAN (NYSE:JAN) from a strong-buy rating to a hold rating in a research report released on Tuesday,Zacks reports.

Other equities analysts have also issued reports about the company. Scotiabank increased their price objective on JAN from $31.00 to $33.00 and gave the company a “sector outperform” rating in a report on Thursday, September 17th. Wall Street Zen upgraded JAN from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Compass Point assumed coverage on JAN in a research report on Wednesday, September 16th. They set a “neutral” rating and a $37.00 price target on the stock. Wells Fargo & Company cut their price target on JAN from $35.00 to $34.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Barclays cut their price target on JAN from $34.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 13th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, JAN presently has an average rating of “Moderate Buy” and an average target price of $32.31.

JAN Stock Down 3.1%

Shares of JAN stock opened at $28.32 on Tuesday. JAN has a 52 week low of $22.76 and a 52 week high of $32.83. The firm’s 50-day simple moving average is $30.00 and its two-hundred day simple moving average is $28.27.

JAN (NYSE:JAN) last released its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The firm had revenue of $216.46 million for the quarter, compared to analysts’ expectations of $203.32 million. The firm’s quarterly revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Research analysts expect that JAN will post 0.97 earnings per share for the current year.

JAN Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 29th. Investors of record on Friday, December 18th will be paid a dividend of $0.0475 per share. The ex-dividend date of this dividend is Friday, December 18th. This represents a $0.57 annualized dividend and a yield of 2.0%.

Hedge Funds Weigh In On JAN

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Engineers Gate Manager LP bought a new position in JAN in the 2nd quarter worth about $15,274,000. Wellington Management Group LLP bought a new stake in shares of JAN during the 2nd quarter valued at about $8,739,000. WINTON GROUP Ltd bought a new stake in shares of JAN during the 2nd quarter valued at about $2,985,000. Readystate Asset Management LP purchased a new position in shares of JAN during the second quarter worth about $1,724,000. Finally, State of Alaska Department of Revenue grew its holdings in shares of JAN by 57.6% during the third quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company’s stock worth $1,082,000 after purchasing an additional 13,367 shares in the last quarter. 6.27% of the stock is currently owned by hedge funds and other institutional investors.

JAN News Summary

Here are the key news stories impacting JAN this week:

• Neutral Sentiment: The most relevant available fundamental backdrop remains JAN’s latest quarterly report: earnings of $0.05 per share missed the $0.23 analyst consensus, although revenue of $216.46 million exceeded estimates and increased 45.4% year over year. Management maintained fiscal 2026 EPS guidance of $0.95 to $0.98, which may provide some support but does not eliminate concerns about profitability and the earnings shortfall.

JAN Company Profile

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.